Tilray Medical is leaving New Zealand’s medical cannabis market to focus on its MMJ operations in Australia.
The Sydney-based medical cannabis company said its final day operating in New Zealand will be May 31, according to The Post.
ADVERTISEMENT
Tilray Medical is a division of Canadian operator Tilray Brands, which has offices in Leamington, Ontario, and New York.
“Our priority is to manage this transition effectively, minimizing any disruption and ensuring Tilray patients in New Zealand have access to necessary treatments during and after the transition period,” Tilray Medical, the first medical cannabis company to operate in New Zealand, told The Post in a statement.
The company, which reported international sales of $13.9 million during the three months ended Feb. 28, said no
Read full article on Marijuana Business Daily
